CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 70% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Biora Therapeutics Inc. - BIOR CFD

2.8984
12.13%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0532
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.024929 %
Charges from full value of position ($-4.74)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.024929%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.002707 %
Charges from full value of position ($0.51)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.002707%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.01
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.2984
Open 3.2984
1-Year Change 76.27%
Day's Range 2.7984 - 3.2984
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Nov 4, 2024 2.8984 -0.4000 -12.13% 3.2984 3.3084 2.7684
Nov 1, 2024 3.2984 -0.0100 -0.30% 3.3084 3.4284 3.2984
Oct 31, 2024 3.3884 -0.0600 -1.74% 3.4484 3.4784 3.3084
Oct 30, 2024 3.4484 -0.1000 -2.82% 3.5484 3.5484 3.3484
Oct 29, 2024 3.4784 -0.2800 -7.45% 3.7584 3.8184 3.3984
Oct 28, 2024 4.3584 0.0900 2.11% 4.2684 4.3984 3.9984
Oct 25, 2024 3.8984 0.4300 12.40% 3.4684 4.1984 3.4684
Oct 24, 2024 3.4984 0.0000 0.00% 3.4984 3.5984 3.2984
Oct 23, 2024 3.7484 -0.6000 -13.80% 4.3484 4.3484 3.6384
Oct 22, 2024 4.4684 0.0200 0.45% 4.4484 4.6284 4.3784
Oct 21, 2024 4.4584 0.1500 3.48% 4.3084 4.5884 4.0584
Oct 18, 2024 4.2584 -1.2616 -22.86% 5.5200 5.5200 4.0884
Oct 17, 2024 0.5520 -0.0125 -2.21% 0.5645 0.5724 0.5291
Oct 16, 2024 0.5875 0.0356 6.45% 0.5519 0.5909 0.5334
Oct 15, 2024 0.5430 0.0170 3.23% 0.5260 0.5524 0.5211
Oct 14, 2024 0.5229 -0.0055 -1.04% 0.5284 0.5435 0.5184
Oct 11, 2024 0.5490 0.0606 12.41% 0.4884 0.5536 0.4884
Oct 10, 2024 0.5445 0.0161 3.05% 0.5284 0.5484 0.5184
Oct 9, 2024 0.5287 0.0003 0.06% 0.5284 0.5436 0.5118
Oct 8, 2024 0.5391 -0.0093 -1.70% 0.5484 0.5485 0.5223

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Biora Therapeutics Inc. Company profile

Progenity (PROG)/Biora Therapeutics (BIOR) is a biotechnology firm focused on the development of oral biotherapeutics. Founded in 2010, the company creates drug-device combinations that enable new therapeutic delivery methods in two main areas:

  • Targeted delivery of therapeutics to the site of disease in the gastrointestinal (GI) tract, to improve outcomes for patients with Inflammatory Bowel Disease (IBD)

  • Systemic biotherapeutic delivery, which is intended to replace injection with needle-free, oral delivery technology

Progenity is also working on diagnostic tools to help characterise the GI tract and diagnose GI diseases such as Small Intestine Bacterial Overgrowth (SIBO). The technologies can pinpoint the location of the disease.

Prior to June 2021, the San Diego, California-based company focused on the prenatal carrier screening and non-invasive prenatal test market. It targeted preconception planning and routine pregnancy management for genetic disease risk assessment.

The company’s operations included anatomic and molecular pathology testing products under an affiliate, Avero Diagnostics.

A former affiliate, Mattison Pathology, a Texas firm trading as Avero Diagnostics, expanded the company’s operations to include anatomic and molecular pathology testing products.

The company also operated a certified laboratory in Michigan that specialised in the molecular testing markets serving women’s health providers in the obstetric, gynaecological, fertility, and maternal foetal medicine speciality areas in the US.

In June 2021, Progenity announced a strategic transformation which included closing the Progenity genetics lab in Ann Arbor, Michigan. It sold the Avero laboratory business in December 2021 as part of the transformation. 

On 12 April 2022, Progenity announced it would change its name to Biora Therapeuctics in the second quarter of 2022. The strategy aims to better reflect its focus of developing targeted and systemic oral delivery of biotherapeutics.

The company will also change its stock symbol on the Nasdaq from PROG to BIOR.  Progenity went public on 19 June 2020. 

Industry: Bio Therapeutic Drugs

4330 La Jolla Village Drive
Suite 200
SAN DIEGO
CALIFORNIA 92122
US

News

RBA meeting preview: No change to policy expected as inflation fight continues

The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.

13:35, 4 November 2024

US elections: Trump leads the polls, but tariff talk spooks investors

As the US elections get closer we look at how Trump’s tariff plans could affect markets.

15:02, 22 October 2024

Gold markets to trade

Last week, we explored the basic fundamental and technical approaches to gold trading. Having covered the key price drivers of this critical asset and how you might use data to trade it, you’re ready to assess the conditions for entry. But there are a range of markets that can effectively give you exposure to gold.

08:00, 21 October 2024

US earnings seasons off to a solid start as focus shifts to tech giants

The US earnings season has started on a positive note, with major banks exceeding expectations and boosting market sentiment.Key themes for the sector include investments in artificial intelligence, capital expenditure returns, and consumer trends in advertising and e-commerce. The S&P 500 continues to climb, driven by strong earnings, resilient economic growth, and the potential for interest rate cuts. Keep an eye on significant support and resistance levels as the market tests new record highs.

14:31, 17 October 2024

ECB Preview: cooling growth and inflation call for another rate cut

Markets are convinced the European Central Bank (ECB) will cut rates by 25 basis points again at Thursday’s meeting.

12:41, 16 October 2024

Australian labour force data forecast to reveal stable jobs market

Australia's labour market remained stable in September 2024, with the unemployment rate forecast to hold at 4.2%, supported by a 25,200 person rise in employment. Despite the economy teetering on the edge of recession, strong hiring trends persist, challenging market economists' predictions.

07:41, 15 October 2024

Applying fundamental and technical strategies to Gold Trading

Last week, we visualised the key potential drivers of gold in a chart focused on recent performance. Understanding the factors that can move gold prices is essential, but translating that knowledge into effective trading strategies is where the real potential can lie.

08:00, 14 October 2024

People also watch

XRP/USD

0.52 Price
+2.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,737.85 Price
+0.040% 1D Chg, %
Long position overnight fee -0.0180%
Short position overnight fee 0.0098%
Overnight fee time 22:00 (UTC)
Spread 0.30

BTC/USD

68,710.45 Price
+2.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Oil - Crude

71.52 Price
-0.030% 1D Chg, %
Long position overnight fee 0.0101%
Short position overnight fee -0.0320%
Overnight fee time 22:00 (UTC)
Spread 0.040

Still looking for a broker you can trust?

Join the 650,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading